160 related articles for article (PubMed ID: 28847548)
1. Cholestatic Alterations in the Critically Ill: Some New Light on an Old Problem.
Jenniskens M; Langouche L; Van den Berghe G
Chest; 2018 Mar; 153(3):733-743. PubMed ID: 28847548
[TBL] [Abstract][Full Text] [Related]
2. Cholestatic liver (dys)function during sepsis and other critical illnesses.
Jenniskens M; Langouche L; Vanwijngaerden YM; Mesotten D; Van den Berghe G
Intensive Care Med; 2016 Jan; 42(1):16-27. PubMed ID: 26392257
[TBL] [Abstract][Full Text] [Related]
3. Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge.
Vanwijngaerden YM; Langouche L; Brunner R; Debaveye Y; Gielen M; Casaer M; Liddle C; Coulter S; Wouters PJ; Wilmer A; Van den Berghe G; Mesotten D
Hepatology; 2014 Jul; 60(1):202-10. PubMed ID: 24213952
[TBL] [Abstract][Full Text] [Related]
4. On the Role of Illness Duration and Nutrient Restriction in Cholestatic Alterations that Occur During Critical Illness.
Jenniskens M; Güiza F; Oorts M; Vander Perre S; Derde S; Dufour T; Thiessen S; Annaert P; Van den Berghe G; Langouche L
Shock; 2018 Aug; 50(2):187-198. PubMed ID: 29076974
[TBL] [Abstract][Full Text] [Related]
5. Impact of parenteral nutrition versus fasting on hepatic bile acid production and transport in a rabbit model of prolonged critical illness.
Vanwijngaerden YM; Langouche L; Derde S; Liddle C; Coulter S; van den Berghe G; Mesotten D
Shock; 2014 Jan; 41(1):48-54. PubMed ID: 24089008
[TBL] [Abstract][Full Text] [Related]
6. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
[TBL] [Abstract][Full Text] [Related]
7. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis.
Recknagel P; Gonnert FA; Westermann M; Lambeck S; Lupp A; Rudiger A; Dyson A; Carré JE; Kortgen A; Krafft C; Popp J; Sponholz C; Fuhrmann V; Hilger I; Claus RA; Riedemann NC; Wetzker R; Singer M; Trauner M; Bauer M
PLoS Med; 2012; 9(11):e1001338. PubMed ID: 23152722
[TBL] [Abstract][Full Text] [Related]
8. Hyperbilirubinemia and cholestasis.
Berk PD; Javitt NB
Am J Med; 1978 Feb; 64(2):311-26. PubMed ID: 415609
[TBL] [Abstract][Full Text] [Related]
9. Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats.
Yan J; Xie G; Liang C; Hu Y; Zhao A; Huang F; Hu P; Liu P; Jia W; Wang X
Sci Rep; 2017 Jun; 7(1):4211. PubMed ID: 28646179
[TBL] [Abstract][Full Text] [Related]
10. Circulating bile acids predict outcome in critically ill patients.
Horvatits T; Drolz A; Rutter K; Roedl K; Langouche L; Van den Berghe G; Fauler G; Meyer B; Hülsmann M; Heinz G; Trauner M; Fuhrmann V
Ann Intensive Care; 2017 Dec; 7(1):48. PubMed ID: 28466463
[TBL] [Abstract][Full Text] [Related]
11. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.
Horvatits T; Drolz A; Roedl K; Rutter K; Ferlitsch A; Fauler G; Trauner M; Fuhrmann V
Liver Int; 2017 Feb; 37(2):224-231. PubMed ID: 27416294
[TBL] [Abstract][Full Text] [Related]
12. Hemoadsorption in isolated conjugated hyperbilirubinemia after extracorporeal membrane oxygenation support. Cholestasis of sepsis: A case report and review of the literature on differential causes of jaundice in ICU patient.
Piwowarczyk P; Kutnik P; Potręć-Studzińska B; Sysiak-Sławecka J; Rypulak E; Borys M; Czczuwar M
Int J Artif Organs; 2019 May; 42(5):263-268. PubMed ID: 30919732
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of cholestasis following allogeneic hematopoietic stem cell transplantation in children: the contribution of serum bile acid levels in relation to other liver function tests.
Zakrzewski JL; Ballauff A; Wieland R; Basu O; Kremens B
Pediatr Hematol Oncol; 2004 Dec; 21(8):697-705. PubMed ID: 15739624
[TBL] [Abstract][Full Text] [Related]
14. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
15. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease.
Koelfat KVK; Schaap FG; Hodin CMJM; Visschers RGJ; Svavarsson BI; Lenicek M; Shiri-Sverdlov R; Lenaerts K; Olde Damink SWM
Clin Nutr; 2017 Oct; 36(5):1403-1410. PubMed ID: 28029505
[TBL] [Abstract][Full Text] [Related]
16. Cholestasis in infancy. A review.
Watson S; Giacoia GP
Clin Pediatr (Phila); 1983 Jan; 22(1):30-6. PubMed ID: 6336683
[TBL] [Abstract][Full Text] [Related]
17. Progressive and Preferential Cellular Accumulation of Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation.
Sharanek A; Burban A; Humbert L; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Drug Metab Dispos; 2017 Dec; 45(12):1292-1303. PubMed ID: 28928138
[TBL] [Abstract][Full Text] [Related]
18. Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
Li Z; Lin B; Lin G; Wu Y; Jie Y; Li X; Ko B; Chong Y; Luo J
PLoS One; 2017; 12(6):e0178580. PubMed ID: 28570655
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
[TBL] [Abstract][Full Text] [Related]
20. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
